Entos lures former Plexxikon CEO to guide push toward the clinic; Ex-Bristol Myers immunology chief finds new home
Around the same time that Entos CEO Tom Miller realized it was time to bring on a CSO to guide the company’s cancer drugs into …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.